Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

58
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
58
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

411
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
411
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

19
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
19
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

479
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
479
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

28
Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
28
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

21
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
21

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Alpha2 agonists for sedation to produce better outcomes for adults with critical illness: a synopsis of the A2B RCT with cost-effectiveness and process evaluation.

Health technology assessment (Winchester, England)·2026
Same author

Development of a national consensus guideline for termination of resuscitation in the out-of-hospital environment.

British paramedic journal·2026
Same author

Carbocisteine or Hypertonic Saline for Acute Respiratory Failure.

The New England journal of medicine·2026
Same author

Health inequalities in out-of-hospital cardiac arrest incidence and bystander cardiopulmonary resuscitation rates in England 2018-23.

Resuscitation·2026
Same author

Technology-Enhanced Strategies to Optimize Positive End-Expiratory Pressure in Patients Receiving Invasive Mechanical Ventilation: A Systematic Review and Meta-Analysis.

Critical care medicine·2026
Same author

Accuracy of major trauma triage using the MATTS tool: a cohort study.

Emergency medicine journal : EMJ·2026

Related Experiment Video

Updated: Aug 8, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.3K

Improving vasopressor use in cardiac arrest.

Gavin D Perkins1, Keith Couper2

  • 1Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK. g.d.perkins@warwick.ac.uk.

Critical Care (London, England)
|March 2, 2023
PubMed
Summary
This summary is machine-generated.

Adrenaline effectively restores circulation during cardiac arrest but has limited impact on long-term survival. Further research is needed on vasopressors and steroids, with current evidence insufficient for other vasopressors.

Keywords:
AdrenalineAdvanced life support drugsCardiac arrestVasopressinVasopressors

More Related Videos

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
05:36

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

Published on: January 30, 2020

7.8K
A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
09:47

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

Published on: April 26, 2015

15.9K

Related Experiment Videos

Last Updated: Aug 8, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.3K
Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine
05:36

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

Published on: January 30, 2020

7.8K
A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique
09:47

A Rat Model of Ventricular Fibrillation and Resuscitation by Conventional Closed-chest Technique

Published on: April 26, 2015

15.9K

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Pharmacology

Background:

  • The Chain of Survival emphasizes early interventions for cardiac arrest.
  • Despite these measures, many patients remain in cardiac arrest.
  • Vasopressors are a key component of resuscitation algorithms.

Purpose of the Study:

  • To review the current evidence base for vasopressors in cardiac arrest resuscitation.
  • To assess the effectiveness of various vasopressor agents and administration routes.

Main Methods:

  • Narrative review of existing scientific literature and randomized trials.
  • Analysis of data on adrenaline, vasopressin, and other vasopressors.
  • Evaluation of evidence for different vascular access routes and calcium chloride use.

Main Results:

  • Adrenaline (1 mg) is highly effective for return of spontaneous circulation (NNT 4) but less so for long-term survival (NNT 111).
  • Randomized trials show no improved long-term outcomes with vasopressin or high-dose adrenaline.
  • Evidence for other vasopressors is insufficient; routine calcium chloride is not recommended.

Conclusions:

  • Adrenaline's efficacy is primarily in achieving return of spontaneous circulation, not long-term survival.
  • Further trials are needed to explore steroid-vasopressin interactions.
  • Current evidence does not support routine use of calcium chloride or certain vasopressors; optimal vascular access is under investigation.